1 - 10 out of 10Page size: 10
  1. 2023

  2. Evidence for effect of L-serine, a novel therapy for GRIN2B-related neurodevelopmental disorder

    den Hollander, B., Veenvliet, A. R. J., Rothuizen-Lindenschot, M., van Essen, P., Peters, G., Santos-Gómez, A., Olivella, M., Altafaj, X., Brands, M. M., Jacobs, B. A. W. & van Karnebeek, C. D., 1 Mar 2023, In: Molecular genetics and metabolism. 138, 3, 107523.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2022

  4. Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review

    van der Ree, M. H., van Dussen, L., Rosenberg, N., Stolwijk, N., van den Berg, S., van der Wel, V., Jacobs, B. A. W., Wilde, A. A. M., Hollak, C. E. M. & Postema, P. G., 22 Nov 2022, In: EP Europace. 24, 11, p. 1809-1823 15 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Recurrent metabolic alkalosis following ketone body treatment of adult mitochondrial trifunctional protein deficiency: A case report

    Stolwijk, N. N., Langeveld, M., Jacobs, B. A. W., Vogt, L., Haverkamp, J. A., Ferdinandusse, S. & Hollak, C. E. M., 1 Sep 2022, In: JIMD reports. 63, 5, p. 407-413 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Everolimus Concentration in Saliva to Predict Stomatitis: A Feasibility Study in Patients with Cancer

    Molenaar-Kuijsten, L., Verheijen, R. B., Jacobs, B. A. W., Thijssen, B., Rosing, H., Dorlo, T. P. C., Beijnen, J. H., Steeghs, N. & Huitema, A. D. R., 1 Aug 2022, In: Therapeutic drug monitoring. 44, 4, p. 520-526 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. 2021

  8. Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid

    Polak, Y., Jacobs, B. A. W. & Kemper, E. M., 28 Sep 2021, In: Frontiers in pharmacology. 12, 758210.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics

    Molenaar-Kuijsten, L., Jacobs, B. A. W., Kurk, S. A., May, A. M., Dorlo, T. P. C., Beijnen, J. H., Steeghs, N. & Huitema, A. D. R., 1 Jul 2021, In: Cancer medicine. 10, 14, p. 4781-4789 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Population Pharmacokinetics of Intracellular 5-Fluorouridine 5′-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine

    Janssen, J. M., Jacobs, B. A. W., Roosendaal, J., Derissen, E. J. B., Marchetti, S., Beijnen, J. H., Huitema, A. D. R. & Dorlo, T. P. C., 1 Jan 2021, In: AAPS journal. 23, 1, 23.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. 2020

  12. Phase I pharmacological study of continuous chronomodulated capecitabine treatment

    Roosendaal, J., Jacobs, B. A. W., Pluim, D., Rosing, H., de Vries, N., van Werkhoven, E., Nuijen, B., Beijnen, J. H., Huitema, A. D. R., Schellens, J. H. M. & Marchetti, S., 1 May 2020, In: Pharmaceutical research. 37, 5, 89.

    Research output: Contribution to journal › Article › Academic › peer-review

  13. 2018

  14. Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials

    Montagut, C., Alonso, V., Escudero, P., Fernández-Martos, C., Salud Salvia, A., Méndez, M., Gallego Plazas, J., Rodriguez, J. R., Martín-Richard, M., Fernández-Plana, J., Aparicio, J., Feliu Batlle, J., García de Albéniz, X., Rojo, F., Fernández, V., Claes, B., Maertens, G. G., Sablon, E., Jacobs, B. A. W. & Maurel, J., 1 Oct 2018, In: Annals of oncology. 29, p. viii182

    Research output: Contribution to journal › Article › Academic › peer-review

  15. Phase I pharmacological study of continuous chronomodulated capecitabine treatment

    Roosendaal, J., Jacobs, B. A. W., Pluim, D., Rosing, H., Nuijen, B., Beijnen, J. H., Huitema, A. D. R., Schellens, J. H. M. & Marchetti, S., 1 Oct 2018, In: Annals of oncology. 29, Suppl. 8, p. viii662-viii663 1872P.

    Research output: Contribution to journal › Meeting Abstract › Academic

ID: 7522737